Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Biometrics
|
November 7, 2003
Dose-finding with two agents in Phase I oncology trials
Peter F Thall, Randall E Millikan, Peter Mueller, et al.
Journal of the American Statistical Association
|
September 8, 2012
Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer
Lu Wang, Andrea Rotnitzky, Xihong Lin, et al.
Statistics in Medicine
|
April 12, 2007
Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring
Peter F Thall, Leiko H Wooten, Christopher J Logothetis, et al.
Cancer
|
June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases
Lance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Urologic Oncology
|
April 10, 2003
Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study
Jeri Kim, Randall E Millikan, Terry L Smith, et al.
Journal of the National Cancer Institute
|
November 1, 2007
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens
Peter F Thall, Christopher Logothetis, Lance C Pagliaro, et al.
The Journal of Urology
|
March 12, 2003
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience
Arlene O Siefker-Radtke, Jason Gee, Yu Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma
Lance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2008
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer
Randall E Millikan, Sijin Wen, Lance C Pagliaro, et al.
The Journal of Urology
|
November 20, 2012
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis
Farshid Dayyani, Bogdan A Czerniak, Kanishka Sircar, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Biometrics
|
November 7, 2003
Dose-finding with two agents in Phase I oncology trials
Peter F Thall, Randall E Millikan, Peter Mueller, et al.
Journal of the American Statistical Association
|
September 8, 2012
Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer
Lu Wang, Andrea Rotnitzky, Xihong Lin, et al.
Statistics in Medicine
|
April 12, 2007
Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring
Peter F Thall, Leiko H Wooten, Christopher J Logothetis, et al.
Cancer
|
June 5, 2003
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases
Lance C Pagliaro, Ebrahim S Delpassand, Dallas Williams, et al.
Urologic Oncology
|
April 10, 2003
Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study
Jeri Kim, Randall E Millikan, Terry L Smith, et al.
Journal of the National Cancer Institute
|
November 1, 2007
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens
Peter F Thall, Christopher Logothetis, Lance C Pagliaro, et al.
The Journal of Urology
|
March 12, 2003
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience
Arlene O Siefker-Radtke, Jason Gee, Yu Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma
Lance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2008
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer
Randall E Millikan, Sijin Wen, Lance C Pagliaro, et al.
The Journal of Urology
|
November 20, 2012
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis
Farshid Dayyani, Bogdan A Czerniak, Kanishka Sircar, et al.
Page
of 4